Showing results (141-150 of 436) with videos related to
Sort By:
Pageof 44
European Journal of Gastroenterology & Hepatology|December 4, 2025
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trialEmily C L Wong, Nazmus Khan, Parambir S Dulai, et al.The American Journal of Gastroenterology|February 2, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis with Severe Endoscopic DiseaseEmily C L Wong, Vipul Jairath, Parambir S Dulai, et al.Inflammatory Bowel Diseases|January 8, 2019
Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel DiseaseNeeraj Narula, Maria Ines Pinto-Sanchez, Natalia Causada Calo, et al.Journal of Clinical Medicine|September 23, 2022
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective StudyMaximilian Kutschera, Valentin Ritschl, Berthold Reichardt, et al.Gastrointestinal Endoscopy|May 29, 2020
Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trialWalter Reinisch, Daniel S Mishkin, Young S Oh, et al.Journal of Crohn'S & Colitis|November 12, 2024
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND TrialEmily C L Wong, Parambir S Dulai, John K Marshall, et al.Arthritis Research & Therapy|January 30, 2008
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin diseaseRainer Zenz, Robert Eferl, Clemens Scheinecker, et al.Inflammatory Bowel Diseases|February 26, 2011
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, et al.European Journal of Gastroenterology & Hepatology|November 19, 2003
Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?Marieluise Harrer, Walter Reinisch, Clemens Dejaco, et al.The American Journal of Gastroenterology|September 27, 2007
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertensionArnulf Ferlitsch, Alexander Teml, Walter Reinisch, et al.Pageof 44